LIMK2 is emerging as a cancer cell survival factor that plays a role in chemotherapy resistance in Neuroblastoma cell lines[28, 32] and p53-mediated survival of cancer cells following DNA damage [33]. The gene discussed is TP53; the disease is cancer.